Clinical presentation of peritoneal mesothelioma

被引:76
|
作者
Acherman, YI
Welch, LS
Bromley, CM
Sugarbaker, PH
机构
[1] Washington Hosp Ctr, Washington Canc Inst, Washington, DC 20010 USA
[2] Washington Hosp Ctr, Dept Occupat & Environm Med, Washington, DC USA
[3] Biostat Solut LLC, Damascus, Syria
关键词
ascites; cytoreductive surgery; intraperitoneal chemotherapy; peritoneal mesothelioma; signs; symptoms;
D O I
10.1177/030089160308900307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To describe the clinical presentation of peritoneal mesothelioma and its impact on survival. Methods: Data was collected from 51 patients with peritoneal mesothelioma treated at the Washington Cancer Institute. The demographic, clinical and pathologic information were analyzed. Results: Pain was the most common symptom (recorded in 33% of patients); increased abdominal girth occurred in 31%, increased abdominal girth and pain in 5%, and a new onset hernia in 12%. In an additional 14% of patients, a variety of other clinical findings led to the diagnosis. There was a statistically significant difference in survival by gender, weight loss and volume of disease. Conclusions: Pain was the most common initial presenting symptom, with increased abdominal girth as a second. A more favorable prognosis occurred in women with a small disease volume.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 50 条
  • [41] Advances in malignant peritoneal mesothelioma
    Cao, Shoubo
    Jin, Shi
    Cao, Jingyan
    Shen, Jing
    Hu, Jing
    Che, Dehai
    Pan, Bo
    Zhang, Jiawen
    He, Xiaoxi
    Ding, Dian
    Gu, Feifei
    Yu, Yan
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (01) : 1 - 10
  • [42] Benign multicystic peritoneal mesothelioma
    Jerbi, M
    Hidar, S
    Ziadi, S
    Khairi, H
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 93 (03) : 267 - 268
  • [43] Experience with peritoneal mesothelioma at the Milan National Cancer Institute
    Deraco, Marcello
    Baratti, Dario
    Cabras, Antonello Domenico
    Zaffaroni, Nadia
    Perrone, Federica
    Villa, Raffaella
    Jocolle, Jenny
    Balestra, Maria Rosaria
    Kusamura, Shigeki
    Laterza, Barbara
    Pilotti, Silvana
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2010, 2 (02) : 76 - 84
  • [44] Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective Study
    C. Brigand
    O. Monneuse
    F. Mohamed
    A. C. Sayag-Beaujard
    S. Isaac
    F. N. Gilly
    O. Glehen
    Annals of Surgical Oncology, 2006, 13 : 405 - 412
  • [45] Diffuse malignant peritoneal mesothelioma
    Shih, Chih-An
    Ho, Szu-Pei
    Tsay, Feng-Woei
    Lai, Kwok-Hung
    Hsu, Ping-I
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2013, 29 (11) : 642 - 645
  • [46] Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma
    Pillai, Krishna
    Pourgholami, Mohammad Hossein
    Chua, Terence C.
    Morris, David Lawson
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (06) : 987 - 994
  • [47] Experience with peritoneal mesothelioma at the Milan National Cancer Institute
    Marcello Deraco
    Dario Baratti
    Antonello Domenico Cabras
    Nadia Zaffaroni
    Federica Perrone
    Raffaella Villa
    Jenny Jocollè
    Maria Rosaria Balestra
    Shigeki Kusamura
    Barbara Laterza
    Silvana Pilotti
    World Journal of Gastrointestinal Oncology, 2010, 2 (02) : 76 - 84
  • [48] Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma?
    Pillai, Krishna
    Pourgholami, Mohammad H.
    Chua, Terence C.
    Morris, David L.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2013, 3 (03): : 312 - 322
  • [49] Analysis of prognostic factors of patients with malignant peritoneal mesothelioma
    Yin, Wenjie
    Zheng, Guoqi
    Yang, Kunna
    Song, Hui
    Liang, Yufei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [50] Malignant peritoneal mesothelioma: a review
    Broeckx, Glenn
    Pauwels, Patrick
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (05) : 537 - 542